Plain-English translation of NCT07012395 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Ulcerative Colitis research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing three new investigational antibody medications—called , , and —to see if they can help people with moderate to severe ulcerative colitis. The study will test each medication on its own, and also test combinations of them together. The goal is to understand whether these treatments are safe and effective at reducing symptoms and improving quality of life.
Ulcerative colitis can be disabling and difficult to treat, especially when it's moderate to severe. Current treatments don't work for everyone, so researchers are developing new medications to give patients more options and better control of their disease.
You likely qualify if…
You likely don't qualify if…
The trial has two parts. First, some participants will receive the open-label medication (meaning everyone knows what they're getting) to check for safety and early signs of effectiveness. Later, other participants will be randomly assigned to receive one of the test treatments or a placebo (dummy pill) in a blinded fashion (meaning neither you nor the researchers will know which you received). Throughout the study, you'll have regular clinic visits for check-ups, blood work, and possibly endoscopies to monitor how well the treatment is working.
AI-generated summary from trial data · Jun 2, 2026 · Not medical advice
United States